X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE ALKEM LABORATORIES SUVEN LIFE/
ALKEM LABORATORIES
 
P/E (TTM) x 16.3 - - View Chart
P/BV x 3.9 6.7 58.0% View Chart
Dividend Yield % 0.5 0.7 69.6%  

Financials

 SUVEN LIFE   ALKEM LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
ALKEM LABORATORIES
Mar-16
SUVEN LIFE/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2291,589 14.4%   
Low Rs1511,232 12.3%   
Sales per share (Unadj.) Rs42.7417.5 10.2%  
Earnings per share (Unadj.) Rs6.956.3 12.2%  
Cash flow per share (Unadj.) Rs8.564.7 13.2%  
Dividends per share (Unadj.) Rs1.0012.70 7.9%  
Dividend yield (eoy) %0.50.9 58.5%  
Book value per share (Unadj.) Rs52.4292.9 17.9%  
Shares outstanding (eoy) m127.28119.57 106.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.4 131.5%   
Avg P/E ratio x27.725.1 110.6%  
P/CF ratio (eoy) x22.221.8 102.1%  
Price / Book Value ratio x3.64.8 75.2%  
Dividend payout %14.622.6 64.7%   
Avg Mkt Cap Rs m24,158168,653 14.3%   
No. of employees `0001.0NA-   
Total wages/salary Rs m5229,171 5.7%   
Avg. sales/employee Rs Th5,349.7NM-  
Avg. wages/employee Rs Th513.5NM-  
Avg. net profit/employee Rs Th858.1NM-  
INCOME DATA
Net Sales Rs m5,43549,915 10.9%  
Other income Rs m2111,645 12.8%   
Total revenues Rs m5,64651,561 11.0%   
Gross profit Rs m1,2918,482 15.2%  
Depreciation Rs m2141,006 21.3%   
Interest Rs m57671 8.5%   
Profit before tax Rs m1,2318,451 14.6%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3591,606 22.3%   
Profit after tax Rs m8726,731 13.0%  
Gross profit margin %23.717.0 139.7%  
Effective tax rate %29.219.0 153.4%   
Net profit margin %16.013.5 119.0%  
BALANCE SHEET DATA
Current assets Rs m4,91727,062 18.2%   
Current liabilities Rs m1,18615,324 7.7%   
Net working cap to sales %68.623.5 291.9%  
Current ratio x4.11.8 234.8%  
Inventory Days Days6267 93.4%  
Debtors Days Days3141 74.6%  
Net fixed assets Rs m3,15412,610 25.0%   
Share capital Rs m127239 53.2%   
"Free" reserves Rs m6,54334,490 19.0%   
Net worth Rs m6,67035,027 19.0%   
Long term debt Rs m2591,212 21.4%   
Total assets Rs m8,15754,387 15.0%  
Interest coverage x22.713.6 166.6%   
Debt to equity ratio x00 112.4%  
Sales to assets ratio x0.70.9 72.6%   
Return on assets %11.413.6 83.7%  
Return on equity %13.119.2 68.0%  
Return on capital %18.624.9 74.7%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m4,9966,563 76.1%   
Fx outflow Rs m9593,012 31.8%   
Net fx Rs m4,0373,552 113.7%   
CASH FLOW
From Operations Rs m1,0887,259 15.0%  
From Investments Rs m-3,1071,864 -166.7%  
From Financial Activity Rs m-300-9,273 3.2%  
Net Cashflow Rs m-2,319-150 1,545.7%  

Share Holding

Indian Promoters % 63.4 66.9 94.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 33.1 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 0.0 -  
Shareholders   37,287 68,381 54.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  UNICHEM LAB  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 22, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS